To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·09-12 07:13
      ARKG Investment Tracker position change: Decreased position in Alamar Biosciences by 32,022 shares, the number of shares held decreased 3.22% compared to the previous period and now represents 1.49% of the total position.
      45Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-12 07:13
      ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 56,268 shares, the number of shares held decreased 3.22% compared to the previous period and now represents 2.37% of the total position.
      3Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-12 07:13
      ARKG Investment Tracker position change: Decreased position in Freenome, Inc. by 24,111 shares, the number of shares held decreased 3.22% compared to the previous period and now represents 0.61% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-12 07:13
      ARKG Investment Tracker position change: Decreased position in Veracyte by 30,861 shares, the number of shares held decreased 3.22% compared to the previous period and now represents 2.17% of the total position.
      27Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-12 07:13
      ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 73,035 shares, the number of shares held decreased 3.22% compared to the previous period and now represents 2.25% of the total position.
      15Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-12 07:13
      ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 59,373 shares, the number of shares held decreased 3.22% compared to the previous period and now represents 2.33% of the total position.
      187Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-12 07:13
      ARKG Investment Tracker position change: Decreased position in Natera by 8,019 shares, the number of shares held decreased 3.22% compared to the previous period and now represents 4.26% of the total position.
      9Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-12 07:13
      ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 17,037 shares, the number of shares held decreased 3.22% compared to the previous period and now represents 4.46% of the total position.
      65Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-12 07:13
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 76,469 shares, the number of shares held decreased 2.67% compared to the previous period and now represents 1.82% of the total position.
      38Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·09-12 07:13
      ARKG Investment Tracker position change: Decreased position in Eli Lilly by 2,106 shares, the number of shares held decreased 3.19% compared to the previous period and now represents 3.83% of the total position.
      14Comment
      Report
      • empty
        No followers yet
       
       
       
       

      Most Discussed